Stockscreener 앱 받기
4.18
2.79%
-0.12
전일 마감가:
$4.30
열려 있는:
$4.3
하루 거래량:
3.61M
Relative Volume:
0.58
시가총액:
$1.25B
수익:
$38.03M
순이익/손실:
$-146.40M
주가수익비율:
-8.0385
EPS:
-0.52
순현금흐름:
$-121.38M
1주 성능:
-4.78%
1개월 성능:
-10.87%
6개월 성능:
+43.15%
1년 성능:
+65.22%
1일 변동 폭
$4.145
$4.40
1주일 범위
$4.145
$4.55
52주 변동 폭
$1.8906
$5.82
앱셀레라바이오로직스 Stock (ABCL) Company Profile
명칭
Abcellera Biologics Inc
전화
(604) 559-9005
주소
150 W 4TH AVENUE, VANCOUVER
ABCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
4.18 | 1.28B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
앱셀레라바이오로직스 Stock (ABCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | Leerink Partners | Outperform |
| 2024-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-02-22 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-10-13 | 재개 | Piper Sandler | Overweight |
| 2023-02-28 | 개시 | Cowen | Outperform |
| 2022-12-15 | 개시 | Goldman | Buy |
| 2022-11-16 | 개시 | Truist | Buy |
| 2021-12-21 | 개시 | The Benchmark Company | Buy |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-01-05 | 개시 | Berenberg | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Outperform |
| 2021-01-05 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | Stifel | Buy |
모두보기
앱셀레라바이오로직스 주식(ABCL)의 최신 뉴스
Volume spikes in AbCellera Biologics Inc. stock – what they meanWeekly Profit Analysis & Smart Allocation Stock Reports - Newser
Applying Elliott Wave Theory to AbCellera Biologics Inc.July 2025 Drop Watch & Fast Moving Trade Plans - Newser
Applying chart zones and confluence areas to AbCellera Biologics Inc.Earnings Recap Report & Real-Time Volume Triggers - Newser
Has AbCellera Biologics Inc. formed a bullish divergenceWeekly Profit Report & Fast Exit and Entry Strategy Plans - Newser
Can Traders Expect Breakout From AbCellera Biologics Inc. This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Can Traders Expect Breakout From AbCellera Biologics Inc. This WeekMarket Movers & Reliable Price Action Trade Plans - beatles.ru
Chart based analysis of AbCellera Biologics Inc. trends2025 Earnings Surprises & Stock Portfolio Risk Control - Newser
Real time scanner hits for AbCellera Biologics Inc. explainedMarket Sentiment Review & Weekly High Conviction Trade Ideas - Newser
Evaluating AbCellera Biologics Inc. with trendline analysis2025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - Newser
Will AbCellera Biologics Inc. outperform the market2025 Short Interest & Growth Oriented Trading Recommendations - Newser
Truist Financial Reiterates a Buy Rating on AbCellera Biologics (ABCL), Sets a $10 PT - MSN
How to build a dashboard for AbCellera Biologics Inc. stockWeekly Trend Recap & Community Verified Swing Trade Signals - Newser
How to recover losses in AbCellera Biologics Inc. stockQuarterly Profit Report & AI Optimized Trade Strategies - Newser
Can a trend reversal in AbCellera Biologics Inc. lead to recovery2025 Technical Overview & Daily Stock Trend Watchlist - Newser
What indicators show strength in AbCellera Biologics Inc.Rate Hike & Verified Momentum Stock Watchlist - Newser
Momentum divergence signals in AbCellera Biologics Inc. chart2025 Price Action Summary & Low Risk Entry Point Tips - Newser
Chart overlay techniques for tracking AbCellera Biologics Inc.2025 Year in Review & Reliable Entry Point Trade Alerts - Newser
AbCellera Biologics Inc.’s volatility index tracking explainedWeekly Investment Report & Fast Momentum Entry Tips - Newser
Analyzing drawdowns of AbCellera Biologics Inc. with statistical toolsWall Street Watch & Free Daily Entry Point Trade Alerts - Newser
Price momentum metrics for AbCellera Biologics Inc. explainedBuy Signal & Reliable Price Breakout Signals - Newser
Best data tools to analyze AbCellera Biologics Inc. stock2025 Dividend Review & Weekly Market Pulse Updates - Newser
What’s the recovery path for long term holders of AbCellera Biologics Inc. - Newser
Smart tools for monitoring AbCellera Biologics Inc.’s price actionWeekly Risk Report & AI Forecast for Swing Trade Picks - Newser
Analyzing net buyer seller activity in AbCellera Biologics Inc.Weekly Earnings Recap & Capital Protection Trading Alerts - Newser
Advanced analytics toolkit walkthrough for AbCellera Biologics Inc.Market Risk Analysis & High Accuracy Swing Entry Alerts - Newser
앱셀레라바이오로직스 (ABCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.96%
1.09%
자본화:
|
볼륨(24시간):